Danmei Xu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Regulatory T Cells

Chronic Myeloid Leukemia

Top Venues

Blood cancer journal

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, Jane F Apperley, David M Weinstock, Hans-Guido Wendel, Jude Fitzgibbon
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma. Blood cancer journal 14 (1) (2024)
Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, Jane F Apperley, David M Weinstock, Hans-Guido Wendel, Jude Fitzgibbon
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma. Blood cancer journal 14 (1) (2024)
Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, Jane F Apperley, David M Weinstock, Hans-Guido Wendel, Jude Fitzgibbon
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma. Blood cancer journal 14 (1) (2024)
Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, Jane F Apperley, David M Weinstock, Hans-Guido Wendel, Jude Fitzgibbon
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma. Blood cancer journal 14 (1) (2024)
Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, Jane F Apperley, David M Weinstock, Hans-Guido Wendel, Jude Fitzgibbon
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma. Blood cancer journal 14 (1) (2024)
Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, Jane F Apperley, David M Weinstock, Hans-Guido Wendel, Jude Fitzgibbon
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma. Blood cancer journal 14 (1) (2024)
Danmei Xu, Simone Claudiani, Kikkeri Naresh, Stuart Mucklow, Pratap Neelakantan, Eva Yebra, Jane F Apperley, Jamshid Khorashad, Dragana Milojkovic
Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1. Leukemia & lymphoma 60 (12) (2019)